CoreWeave (CRWV) Downgraded to Hold by BofA Despite AI Momentum

Bank of America downgraded CoreWeave (CRWV) to "Hold" from "Buy" due to valuation concerns after a 145% rally since Q1 earnings, with the price target raised from $76 to $185. Analyst Bradley Sills noted the stock trades at a premium 25x 2027 EV/EBIT, indicating much of the near-term upside is priced in despite optimism around CoreWeave's AI infrastructure offerings and a growing market. Sills also expressed concern over the company's reliance on debt to fund capital expenditures, estimating $21 billion in negative free cash flow through 2027.

Analysis

Bank of America has downgraded CoreWeave, Inc. (CRWV) to "Hold" from "Buy," citing valuation concerns after the stock's 145% rally since its first-quarter earnings. Despite this downgrade, the price target was substantially increased from $76 to $185, reflecting a positive long-term view but suggesting that near-term upside is now largely priced in. The stock currently trades at a premium valuation of 25x its estimated 2027 EV/EBIT. This cautious stance is taken despite several positive developments, including a new hyperscaler customer, an expanded $4 billion agreement with OpenAI, and strong top-line momentum within a booming AI infrastructure market projected to reach $206 billion by 2027. However, the analyst highlights a significant financial risk: the company is expected to generate a negative free cash flow of approximately $21 billion through 2027 due to elevated capital expenditures. This concern is magnified by CoreWeave's historical reliance on debt to fund 85% of its capex, creating uncertainty about the cost and availability of future financing required to support its aggressive growth strategy.

Key Decisions for Investors

• Investors with existing positions should consider the stock's 145% recent rally and the analyst's view that upside is now limited, potentially making it prudent to trim positions and capitalize on recent gains.
• Potential new investors should exercise caution due to the premium valuation and consider waiting for a more favorable entry point, as the current price already reflects significant future growth.
• Monitor the company's capital structure and future debt financing closely, as its ability to fund an estimated $21 billion in negative free cash flow through 2027 is the primary risk highlighted in the analysis.
• While market demand remains strong, pay close attention to the company’s ability to manage its capital expenditures and cost of debt, as these factors will be critical to sustaining its growth trajectory.